BASILEA PHARMACEUTICALS A/S: Financial statements 2015
CVR: 30723732
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
BASILEA PHARMACEUTICALS A/S (CVR 30723732) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -60,472 and a net result of DKK -30,567 compared with DKK -14,143 the year before. Equity in the 2015 report amounted to DKK 4,184,179. The solvency ratio was 92.9%.
- Gross Profit
- DKK -60,472
- Profit/Loss
- DKK -30,567
- Equity
- DKK 4,184,179
- Total Assets
- DKK 4,502,379
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -60 t. | -31 t. | 4.2 mio. | - |
| 2014 | - | -68 t. | -14 t. | 4.2 mio. | - |
| 2013 | - | -318 t. | -274 t. | 4.2 mio. | - |
| 2012 | - | 3.9 mio. | 920 t. | 4.5 mio. | - |
Official annual report
How creditworthy is BASILEA PHARMACEUTICALS A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
BASILEA PHARMACEUTICALS A/S has published its annual report for 2014. Gross profit came to DKK -67,642, and the net result was DKK -14,143.
As of April 28, 2015, Arne Wiechmann has joined the board of directors of BASILEA PHARMACEUTICALS A/S.
As of April 28, 2015, Donato Spota has left the board of directors of BASILEA PHARMACEUTICALS A/S.
As of April 28, 2015, Arne Wiechmann is registered as adm. dir. of BASILEA PHARMACEUTICALS A/S.
As of April 28, 2015, Donato Spota has stepped down as direktion of BASILEA PHARMACEUTICALS A/S.
About BASILEA PHARMACEUTICALS A/S
BASILEA PHARMACEUTICALS A/S was a Danish company of the type Aktieselskab based in København V, founded in 2007. The company has been dissolved on 19 September 2017. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 0 employees (2012). In 2016, the company reported a gross profit of DKK -35,500 and a net result of DKK 15,967 compared with DKK -30,567 the year before. Equity in the 2016 report amounted to DKK 4,200,146.